How Iwicki was paid
$30.6M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Options | Incentive | Other | Total |
|---|---|---|---|---|---|
| Mark IwickiChief Executive Officer and Director | $624,208 | $29,429,299 | $532,500 | — | $30,586,007 |
| Chris Cabell, M.D.President and Head of Research and Development | $429,167 | $6,764,872 | $281,250 | — | $7,475,289 |
| David McIntyreChief Financial Officer | $347,216 | $4,899,661 | $272,813 | — | $5,519,690 |
| Milton H. Werner, Ph.D.Former President and Chief Executive Officer | $728,979 | $40,449 | $31,543 | $2,092 | $803,063 |
What changed and why
- $30.6MMark Iwicki joined as Chief Executive Officer on February 14, 2025, receiving total compensation of $30,586,007.
- Option awards comprised the vast majority of executive compensation due to new hire grants and warrant adjustment options.
- 125%Annual cash bonuses were paid at 125% of target following successful transitions into Phase 3 studies.
- Milton Werner stepped down as CEO and received separation benefits including accelerated time-based equity awards.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.